FDA Decision Alert: Questcor Pharma
QCOR: Google Finance Profile
(RTTNews) - In less than a week, the Food and Drug Administration will take a final decision on Questcor Pharmaceuticals Inc.'s (QCOR) H.P. Acthar Gel for the proposed expanded indication of infantile spasms.
The regulatory agency was originally scheduled to rule on Acthar's expanded indication in June. But the deadline was extended in order to review information regarding labeling and potential post-approval commitments that they solicited from Questcor.
Showing posts with label Acthar Gel. Show all posts
Showing posts with label Acthar Gel. Show all posts
Subscribe to:
Posts (Atom)